[1] 陈小平,毛节明,郭静萱,等.脂蛋白(a)与冠状动脉病变[J].中华心血管病杂志,2002,30(10):589.
[2] KOENIG W,TWARDELLA D,BRENNER H,et al.Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events:more than simply a marker of glomerular filtration rate[J].Clin Chem,2005,51(2):321.
[3] NAGESH CM,ROY A.Role of biomarkers in risk stratification of acute coronary syndrome[J].Indian J Med Res,2010,132:627.
[4] GENSINI GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(6):606.
[5] 杨惠月,边云飞,李小雷,等.青年冠心病患者临床危险因素分析[J].山西医科大学学报,2015,46(5):396.
[6] 孙乙铭.老年肺源性心脏病合并冠心病患者的相关因素分析[J].临床合理用药杂志,2015,8(12):86.
[7] LIBBY P.Inflammation in atheronsclerosis[J].Arterioscler Thromb Vasc Biol,2012,32(9):2045.
[8] AFANAS'EVA OI,KLESAREVA EA,LEVASHEV PA,et al.Autoantibodies against lipoprotein(a) in patients with coronary heart disease[J].Kardiologiia,2014,54(6):4.
[9] MARANHAO RC,CARVALHO PO,STRUNZ CC,et al.Lipoprotein(a):structure,pathophysiology and clinical implications[J].Arq Bras Cardiol,2014,103(1):76.
[10] GURDASANI D,SJOUKE B,TSIMIKAS S,et al.Lipoprotein(a) and risk of coronary,cerebrovascular,and peripheral artery disease:the EPIC-Norfolk prospective population study[J].Arterioscler Thromb Vasc Biol,2012,32(12):3058.
[11] NESTPEL PJ,BARNES EH,TONKIN AM,et al.Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease[J].Arterioscler Thromb Vasc Biol,2013,33(12):2902.
[12] ORNEK E,MURAT S,DURAN M,et al.The relationship between lipoprotein(a) and coronary artery disease,as well as its variable nature following myocardial infarction[J].Clin Invest Med,2011,34(1):14.
[13] JACOBSON TA.Lipoprotein(a),cardiovascular disease and contemporary management[J].Mayo Clin Proc,2013,88(11):1294.
[14] FERRARO S,MARANO G,BIGANZOLI EM,et al.Prognostic value of cystatin C in acute coronary syndromes:enhancer of atherosclerosis and promising therapeutic target[J].Clin Chem Lab Med,2011,49(9):1397.
[15] KAMPOLI AM,TOUSOULIS D,PAPAGEORGIOU N.et al.Clinical utility of biomarkers in premature atherosclerosis[J].Curr Med Chem,2012,19(16):2521.
[16] KIYOSUE A,HIRATA Y,ANDO J,et al.Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease[J].Circ,2010,74(11):2441.
[17] 郭守玉,龙明智.冠心病患者胱抑素c水平与冠状动脉造影Gensini评分的相关性[J].检验医学与临床,2012,9(4):385.
[18] DOGANER YC,AYDOGAN U,AYDOGDU A,et al.Relationship of cystatin C with coronary artery disease and its severity[J].Coro Artery Dis,2013,24(2):119.
[19] 杨曙光,汤学超.血清胱抑素c水平与冠心病严重程度的关系[J].中国动脉硬化杂志,2014,22(12):1247.